No abstract available.
Aged* ; Humans ; Infant, Newborn*

No abstract available.
Anus, Imperforate*

No abstract available.

BACKGROUND: Knowledge about the degree of risk and location of multiple primary cancers can facilitate the targeting of screening and surveillance practices on follow-up after treatment of cervical cancer. PURPOSE: The retrospective study was performed to evaluate the characteristics of multiple primary malignancies in patients treated for cervical carcinoma. METHOD: From data base file of gynecologic cancer patients between 1976 and 1995, total 20 patients were found to have cervical cancer and another primary malignancy. Their medical records and pathologic slides were reviewed. Follow-up information was obtained from medical records or by telephone. RESULT: There were 8 synchronous and 12 metachronous multiple primary cancers (MPC) among 20 patients. Their mean age was 51 years (range 23 ~ 68 years). The distribution of FIGO stage of the patients with cervical cancer was classified into stage I, 6 patients; stage II, 9 ; and stage III, 5. All patients showed squamous cell type histology of cervical cancer. Eight(40 %) of 20 patients developed second cancer in uterus : 6 malignant mixed Mllerian tumors(MMMT), one endometrial stromal sarcoma, and one endometrial adenocarcinoma. Seven of 8 synchronous type MPC patients are alive (median follow-up, 27 months). In contrast, only one out of 12 metachronous type MPC patients is alive(median follow-up, 114 months). The occurrence of eight malignancies including 6 MMMT, one bladder cancer, and one rectal cancer might be related with previous radiation therapy for cervical cancer. CONCLUSION: These results suggest that routine screening and surveillance work-up might not be necessary in most of patients with cervical cancer. However, the patients with cervical cancer undergoing radiation treatment have to be followed carefully with the consideration of possibility for developing second cancer in the field of irradiation.
Adenocarcinoma ; Follow-Up Studies ; Humans ; Mass Screening ; Medical Records ; Neoplasms, Second Primary ; Rectal Neoplasms ; Retrospective Studies ; Sarcoma, Endometrial Stromal ; Telephone ; Urinary Bladder Neoplasms ; Uterine Cervical Neoplasms ; Uterus

This study was performed to demonstrate the efficacy of combination of cold-knife conization and cold-coagulation for the treatment of cervical intraepithelial neoplasia(CIN). In addition, the accuracy of the colposcopic biopsy and Pap smear compare to conization was determined. Cold-coagulation was performed simultaneously in 151 patients after cold-knife conization for diagnosis and treatment of CIN from Jan. 1995 to Dec. 1996. Medical records and pathologic slides of those patients were reviewed. Histologic comparison between the Pap smear and conization specimens showed agreement with 70 % within one grade difference ; Histologic comparison between the colpodirected punch biopsy and conization specimens showed agreement with 80 %. The margin involvement of conization was seen in 35 patients(23 %). There was a tendency of increasing rate of positive cone margin with grade of the lesion : 14 %(1/7) in CIN 1, 20 %(2/10) in CIN 2, 35 %(31/88) in CIN 3, and 33 %(1/3) in microinvasive cervical cancer. Among these 35 patients, 11 patients underwent hysterectomy and showed residual disease in 4 patients(36 %). Recurrence of CIN was found in 4 patients(16 %) with positive cone margin and 1 patient(0.9 %) with negative cone margin. Bleeding was observed in 13 patients(9 %). Two patients underwent hysterectomy because of severe bleeding. These results suggest that cold-knife conization with cold-coagulation is an effective procedure to reduce recurrence rate of the patients with CIN regardless of status of cone margin and to reduce the severity of bleeding after conization.
Biopsy ; Cervical Intraepithelial Neoplasia* ; Conization* ; Diagnosis* ; Hemorrhage ; Humans ; Hysterectomy ; Medical Records ; Recurrence ; Uterine Cervical Neoplasms

This study was performed to evaluate the survival of the patients found to have metastasis only to the para-aortic or/and supraclavicular lymph nodes at the time of diagnosis of recurrence of the cervical cancer. In addition, the survival was compared between the patients metastasis limited to the para aortic or/and supraclavicular lymph nodes only and those having other concurrent metastatic sites. From Jan. 1991 to Dec. 1995, total 105 patients were identified to have metastasis of para-aortic or/and supraclavicular lymph nodes by computerized tomography(CT) scan or/and percutaneous needle aspiration cytology. Their medical records and cytologic slides were reviewed. The information about survival and disease status was obtained from the last follow-up date in medical records or from interview via telephone. Forty-one(39%) patie-nts showed para-aortic node metastasis: 23 patients(22%), supraclavicular node metastasis; 41(39%) patients, para-aortic and supraclavicular lymph node metastasis. Thirty-one(76%) of 41 patients involving para-aortic lymph node metastasis showed recurrent disease limited to the lymph nodes only: Eight(35%) of 23 patients with supraclavicular lymph node metastasis and sixteen(39%) of 41 patients with both lymph nodes metastasis showed lymph node metastasis only. Supraclavicular lymph node metastasis was found concurrently in 41(50%) of 82 patients with para-aortic lymph node metastasis at the time of recurrence. Forty-two patients(40 %) had been found to have previous pelvic lymph node metastasis at the time of initial treatm ent of the cervical cancer. The 3-year survival was 13.9% in patients with para-aortic lymph node metastasis: 0% with supraclavicular lymph node metastasis: 20.3% in para-aortic and supraclavicular lymph node metastasis. In addition, 3-year survival rate was not significantly different among the groups with different lymph node metastasis. Furthermore, there was no difference in the 3-year survival rate between the patients with lymph node metastasis only and those with other concurrent metastatic sites. These results showed that survival of the patients with metastasis to para-aortic or/and supraclavicular lymph nodes only at the time of diagnosis of recurrent cervical cancer may be still poor and was not different compara to that of the patients with other concurrent sites of metastasis.
Diagnosis* ; Follow-Up Studies ; Humans ; Lymph Nodes* ; Medical Records ; Needles ; Neoplasm Metastasis* ; Prognosis* ; Recurrence* ; Survival Rate ; Telephone ; Uterine Cervical Neoplasms*

The consensus guideline development committee of Korean Society of Gynecologic Oncology was reconvened in March 2012. The committee consisted of 36 experts representing 12 university hospitals and professional organizations. The objective of this committee was to develop standardized guidelines for cervical cancer screening tests for Korean women and to distribute these guidelines to every clinician, eventually improving the quality of medical care. Since the establishment of the consensus guideline development committee, evidence-based guidelines have either been developed de novo considering specific Korean situations or by adaptation of preexisting consensus guidelines from other countries. Recommendations for cervical cancer screening tests, management of atypical squamous and glandular cells, and management of low-grade and high-grade squamous intraepithelial lesions were developed. Additionally, recommendations for human papillomavirus DNA testing and recommendations for adolescent and pregnant women with abnormal cervical screening test results were also included.
Adolescent ; Consensus ; DNA ; Female ; Hospitals, University ; Humans ; Mass Screening ; Pregnant Women ; Societies ; Uterine Cervical Neoplasms